How Vaccines Work
The immunology of vaccination: how presenting a harmless antigen trains adaptive immunity, what memory cells do, and why herd immunity protects the unvaccinated.
A vaccine teaches the adaptive immune system to recognize a pathogen before meeting it. It presents an antigen — a protein fragment, inactivated pathogen, or genetic instructions to build one — without the disease, so that the immune system builds memory at low cost. When the real pathogen arrives, the response is faster and stronger than a naive immune system could mount, which is the entire mechanism.
The immunology
Vaccination activates the adaptive arm of immunity: antigen-presenting cells display fragments to T cells; B cells whose antibodies bind the antigen proliferate and mature; some become long-lived memory cells. On re-exposure, memory B cells respond within days rather than the week or two a first encounter takes — enough time for a pathogen to establish infection, too short for symptoms in most cases (antibodies explains the effector molecules). Adjuvants — aluminum salts or newer MPL — provide the danger signals that license a strong response; mRNA vaccines add instructions for the antigen instead of delivering the antigen itself, and the cell's own machinery produces the antigen to be recognized.
Why herd immunity works
When a sufficient fraction of a population is immune (roughly 80–95% for measles, lower for influenza), chains of transmission break because each case infects fewer than one more. This protects those who cannot be vaccinated — newborns, immunocompromised patients — and is why vaccination is a collective infrastructure, not just personal protection. The threshold depends on how infectious the pathogen is; the bystander effect has an epidemiological cousin in why under-vaccinated clusters ignite outbreaks.
Safety in context
Common side effects (fever, sore arm) are the innate immune system doing its job; serious adverse events are rare and monitored by pharmacovigilance systems that quantify rates against background incidence. The benefits-risk calculus for a vaccine against a dangerous disease is overwhelmingly favorable at population level, which is why smallpox is extinct and polio is nearly so. Related reading: antibodies for the effector molecules, and antibiotic resistance for an evolutionary pressure vaccines uniquely avoid.
Tags
adaptive immunity immunology public health vaccines